Kyverna’s KYSA-8 Trial Completion Puts Autoimmune Cell Therapy in Investor Focus
at www.tipranks.com (Fri, 24-Jul 12:30 PM)
Kyverna Bolsters Legal Team as it Eyes Commercial-Stage Leap with New Chief Legal and Compliance Officer
Market Chameleon (Mon, 22-Jun 9:42 AM)
